BRPI0907519A2 - Antagonistas farmacoforos-pde4-muscarínicos duais - Google Patents

Antagonistas farmacoforos-pde4-muscarínicos duais

Info

Publication number: BRPI0907519A2
Authority: BR; Brazil
Prior art keywords: pharmacophor; pde4; muscarinic; antagonists; dual
Prior art date: 2008-02-06

Application number

BRPI0907519-4A

Other languages

English (en)

Inventor

James Francis Callahan

Guoliang Lin

Zehong Wan

Hongxing Yan

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-02-06

Filing date

2009-02-05

Publication date

2015-07-28

2009-02-05 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2015-07-28 Publication of BRPI0907519A2 publication Critical patent/BRPI0907519A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

BRPI0907519-4A 2008-02-06 2009-02-05 Antagonistas farmacoforos-pde4-muscarínicos duais BRPI0907519A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US2656808P	2008-02-06	2008-02-06
PCT/US2009/033129 WO2009100167A1 (en)	2008-02-06	2009-02-05	Dual pharmacophores-pde4-muscarinic antagonistics

Publications (1)

Publication Number	Publication Date
BRPI0907519A2 true BRPI0907519A2 (pt)	2015-07-28

Family

ID=40935341

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0907519-4A BRPI0907519A2 (pt)	2008-02-06	2009-02-05	Antagonistas farmacoforos-pde4-muscarínicos duais

Country Status (19)

Country	Link
US (1)	US8071588B2 (pt)
EP (1)	EP2247184A4 (pt)
JP (1)	JP2011511083A (pt)
KR (1)	KR20100125295A (pt)
CN (1)	CN101983009A (pt)
AR (1)	AR070563A1 (pt)
AU (1)	AU2009212409A1 (pt)
BR (1)	BRPI0907519A2 (pt)
CA (1)	CA2714418A1 (pt)
CL (1)	CL2009000249A1 (pt)
CR (1)	CR11666A (pt)
DO (1)	DOP2010000239A (pt)
EA (1)	EA201070917A1 (pt)
IL (1)	IL207346A0 (pt)
MX (1)	MX2010008685A (pt)
PE (1)	PE20091563A1 (pt)
TW (1)	TW200946525A (pt)
UY (1)	UY31636A1 (pt)
WO (1)	WO2009100167A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UY33373A (es)	2010-05-10	2011-12-30	Gilead Sciences Inc	?Compuestos de pirazolopiridina bifuncionales, su uso en terapia y composiciones que los comprenden?.
EP3072943B1 (en)	2015-03-26	2018-05-02	Idemitsu Kosan Co., Ltd.	Dibenzofuran/carbazole-substituted benzonitriles
JP2018521021A (ja)	2015-06-11	2018-08-02	バジリア・ファルマスーチカ・インターナショナル・アーゲーＢａｓｉｌｅａＰｈａｒｍａｃｅｕｔｉｃａＩｎｔｅｒｎａｔｉｏｎａｌＡｇ	排出ポンプ阻害剤及びその治療的使用
WO2017089347A1 (en)	2015-11-25	2017-06-01	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3925388A (en) *	1971-08-05	1975-12-09	Squibb & Sons Inc	4-Piperazino-{8 3,4-b{9 pyridine-5-carboxylic acids and esters
US3856799A (en) *	1971-08-05	1974-12-24	Squibb & Sons Inc	Intermediates for production of amino derivatives of pyrazolopyridine carboxylic acids and esters
BE787249A (fr) *	1971-08-05	1973-02-05	Squibb & Sons Inc	Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation
US3833594A (en) *	1971-08-05	1974-09-03	Squibb & Sons Inc	Amino derivatives of pyrazolopyridine carboxylic acids and esters
CA1003419A (en)	1971-11-23	1977-01-11	Theodor Denzel	Process for the production of pyrazolo (3,4-b) pyridines
US3979399A (en) *	1972-11-15	1976-09-07	E. R. Squibb & Sons, Inc.	Amino derivatives of pyrazolopyridine carboxamides
US3840546A (en) *	1972-11-15	1974-10-08	Squibb & Sons Inc	Amino derivatives of pyrazolopyridine carboxamides
US4364948A (en)	1981-09-28	1982-12-21	Ici Americas Inc.	Pyrazolo[3,4-b]pyridine compounds
US6326379B1 (en)	1998-09-16	2001-12-04	Bristol-Myers Squibb Co.	Fused pyridine inhibitors of cGMP phosphodiesterase
US6670364B2 (en) *	2001-01-31	2003-12-30	Telik, Inc.	Antagonists of MCP-1 function and methods of use thereof
US6677365B2 (en)	2001-04-03	2004-01-13	Telik, Inc.	Antagonists of MCP-1 function and methods of use thereof
US6825184B2 (en) *	2001-10-18	2004-11-30	Boehringer Ingelheim Pharmaceuticals, Inc.	1,4-Disubstituted benzo-fused urea compounds
US7544675B2 (en)	2002-04-18	2009-06-09	Ucb, S.A.	Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
UY27927A1 (es)	2002-08-06	2003-12-31	Glaxo Group Ltd	Antagonistas del receptor muscarínico m3 de acetilcolina
GB0230045D0 (en) *	2002-12-23	2003-01-29	Glaxo Group Ltd	Compounds
CN100387598C (zh) *	2002-09-16	2008-05-14	葛兰素集团有限公司	吡唑并[3,4-b]吡啶化合物及其作为磷酸二酯酶抑制剂的用途
EP1613307A4 (en)	2003-04-07	2008-03-12	Glaxo Group Ltd	M SB 3 / SB MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS
UY28417A1 (es)	2003-07-17	2005-02-28	Glaxo Group Ltd	Antagonistas de los receptores muscarinicos de la acetilcolina
PE20050711A1 (es)	2003-07-17	2005-09-10	Glaxo Group Ltd	Compuestos 8-azoniabiciclo[3.2.1] octanos como antagonistas de los receptores muscarinicos de la acetilcolina
PE20050250A1 (es)	2003-07-17	2005-04-08	Glaxo Group Ltd	Antagonistas de los receptores muscarinicos de la acetilcolina
TW200811172A (en)	2003-10-14	2008-03-01	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists
AR046114A1 (es)	2003-10-17	2005-11-23	Glaxo Group Ltd	Compuesto de 8- azoniabiciclo (3.2.1) octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos y uso del compuesto para preparar dicha composicion
TW200524577A (en)	2003-11-04	2005-08-01	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists
UY28646A1 (es)	2003-12-03	2005-06-30	Glaxo Group Ltd	Nuevos antagonistas del receptor muscarinico m3 de acetilcolina
AR046784A1 (es)	2003-12-03	2005-12-21	Glaxo Group Ltd	Compuesto de amina ciclica composicion farmaceutica que lo comprende y su uso para preparar esta ultima
JP2007514704A (ja) *	2003-12-19	2007-06-07	グラクソ　グループ　リミテッド	ピラゾロ［３，４−ｂ］ピリジン化合物およびホスホジエステラーゼ阻害剤としてのその使用
TW200534855A (en)	2004-01-13	2005-11-01	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists
US20090253908A1 (en)	2004-03-11	2009-10-08	Glaxo Group Limited	Novel m3 muscarinic acetylchoine receptor antagonists
US20070179131A1 (en)	2004-03-11	2007-08-02	Jian Jin	Novel M3 Muscarinic Acetylcholine Receptor Antagonists
GB0405933D0 (en)	2004-03-16	2004-04-21	Glaxo Group Ltd	Compounds
GB0405937D0 (en)	2004-03-16	2004-04-21	Glaxo Group Ltd	Compounds
EP1735314A1 (en)	2004-03-16	2006-12-27	Glaxo Group Limited	Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor
US20070185090A1 (en)	2004-03-17	2007-08-09	Jakob Busch-Petersen	Muscarinic acetylchoine receptor antagonists
WO2005094251A2 (en)	2004-03-17	2005-10-13	Glaxo Group Limited	M3muscarinic acetylcholine receptor antagonists
US7384946B2 (en)	2004-03-17	2008-06-10	Glaxo Group Limited	M3 muscarinic acetylcholine receptor antagonists
JP2007529514A (ja)	2004-03-17	2007-10-25	グラクソ　グループ　リミテッド	Ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト
JP2007538005A (ja)	2004-04-07	2007-12-27	グラクソ　グループ　リミテッド	ムスカリン性アセチルコリン受容体アンタゴニスト
PE20060259A1 (es)	2004-04-27	2006-03-25	Glaxo Group Ltd	Compuestos de quinuclidina como antagonistas del receptor de acetilcolina muscarinico
JP2007537261A (ja)	2004-05-13	2007-12-20	グラクソ　グループ　リミテッド	ムスカリン性アセチルコリン受容体アンタゴニスト
AR048976A1 (es)	2004-05-28	2006-06-14	Glaxo Group Ltd	Compuesto derivado de alcohol terciario de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica que lo comprende y su uso para preparar esta ultima
EP1765339A4 (en)	2004-06-30	2009-09-02	Glaxo Group Ltd	ANTAGONISTS OF MUSCARIN ACETYLCHOLIN RECEPTOR
JP2008509159A (ja)	2004-08-05	2008-03-27	グラクソグループリミテッド	ムスカリン性アセチルコリン受容体拮抗薬
JP2008509158A (ja)	2004-08-06	2008-03-27	グラクソグループリミテッド	ムスカリン性アセチルコリン受容体アンタゴニスト
US20090258858A1 (en)	2004-10-29	2009-10-15	Jakob Busch-Petersen	Muscarinic acetylcholine receptor antagonists
US7932247B2 (en)	2004-11-15	2011-04-26	Glaxo Group Limited	M3 muscarinic acetylcholine receptor antagonists
US20090142279A1 (en)	2004-11-15	2009-06-04	Budzik Brian W	Novel m3 muscarinic acetylcholine receptor antagonists
PE20061162A1 (es)	2004-12-06	2006-10-14	Smithkline Beecham Corp	Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanos
PE20060826A1 (es)	2004-12-06	2006-10-08	Smithkline Beecham Corp	Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende
WO2006065755A2 (en)	2004-12-13	2006-06-22	Glaxo Group Limited	Quaternary ammonium salts of fused hetearomatic amines as novel muscarinic acetylcholine receptor antagonists
WO2006065788A2 (en)	2004-12-13	2006-06-22	Glaxo Group Limited	Novel muscarinic acetylcholine receptor antagonists
WO2007018508A1 (en)	2005-07-28	2007-02-15	Glaxo Group Limited	Novel m3 muscarinic acetycholine receptor antagonists
WO2007018514A1 (en)	2005-07-28	2007-02-15	Glaxo Group Limited	Novel m3 muscarinic acetylcholine receptor antagonists
EP1937230A4 (en)	2005-08-02	2009-08-26	Glaxo Group Ltd	M3-MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS
WO2007016639A2 (en)	2005-08-02	2007-02-08	Glaxo Group Limited	M3 muscarinic acetylcholine receptor antagonists
EP1937068A4 (en)	2005-08-18	2010-08-04	Glaxo Group Ltd	ANTAGONISTS OF ACETYLCHOLINE MUSCARINIC RECEPTORS
WO2007123953A2 (en) *	2006-04-19	2007-11-01	Memory Pharmaceuticals Corporation	Phosphodiesterase 4 inhibitors
GB0614570D0 (en) *	2006-07-21	2006-08-30	Glaxo Group Ltd	Compounds

2009
- 2009-02-04 UY UY31636A patent/UY31636A1/es not_active Application Discontinuation
- 2009-02-04 CL CL2009000249A patent/CL2009000249A1/es unknown
- 2009-02-04 AR ARP090100368A patent/AR070563A1/es not_active Application Discontinuation
- 2009-02-04 PE PE2009000165A patent/PE20091563A1/es not_active Application Discontinuation
- 2009-02-04 TW TW098103479A patent/TW200946525A/zh unknown
- 2009-02-05 JP JP2010545973A patent/JP2011511083A/ja active Pending
- 2009-02-05 CA CA2714418A patent/CA2714418A1/en not_active Abandoned
- 2009-02-05 EP EP09708465A patent/EP2247184A4/en not_active Withdrawn
- 2009-02-05 US US12/365,933 patent/US8071588B2/en not_active Expired - Fee Related
- 2009-02-05 BR BRPI0907519-4A patent/BRPI0907519A2/pt not_active IP Right Cessation
- 2009-02-05 WO PCT/US2009/033129 patent/WO2009100167A1/en not_active Ceased
- 2009-02-05 CN CN2009801118845A patent/CN101983009A/zh active Pending
- 2009-02-05 AU AU2009212409A patent/AU2009212409A1/en not_active Abandoned
- 2009-02-05 EA EA201070917A patent/EA201070917A1/ru unknown
- 2009-02-05 KR KR1020107019775A patent/KR20100125295A/ko not_active Withdrawn
- 2009-02-05 MX MX2010008685A patent/MX2010008685A/es unknown
2010
- 2010-08-02 IL IL207346A patent/IL207346A0/en unknown
- 2010-08-03 DO DO2010000239A patent/DOP2010000239A/es unknown
- 2010-09-01 CR CR11666A patent/CR11666A/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
US20090203677A1 (en)	2009-08-13
UY31636A1 (es)	2009-08-03
US8071588B2 (en)	2011-12-06
AR070563A1 (es)	2010-04-21
KR20100125295A (ko)	2010-11-30
TW200946525A (en)	2009-11-16
CN101983009A (zh)	2011-03-02
IL207346A0 (en)	2010-12-30
WO2009100167A1 (en)	2009-08-13
PE20091563A1 (es)	2009-11-05
EP2247184A4 (en)	2012-07-18
MX2010008685A (es)	2010-08-30
CR11666A (es)	2011-04-28
EA201070917A1 (ru)	2011-02-28
CL2009000249A1 (es)	2009-09-11
AU2009212409A1 (en)	2009-08-13
DOP2010000239A (es)	2011-03-31
JP2011511083A (ja)	2011-04-07
CA2714418A1 (en)	2009-08-13
EP2247184A1 (en)	2010-11-10

Publication	Publication Date	Title
NO2018006I1 (no)	2018-02-14	Atezolizumab
DK2340021T3 (da)	2012-12-10	Substituerede pyrrolidin-2-carboxamider
DK2370462T3 (da)	2014-09-08	Glucagon-analoger
DK2342317T3 (da)	2013-03-18	Hængende-dråbe-plade
DE602009000234D1 (de)	2010-11-11	msignals
BRPI0907376A2 (pt)	2015-07-14	Fotobiorretador
EP2258938A4 (en)	2012-09-05	TYPE VEHICLE TO BE PROVIDED
DK3444343T3 (da)	2021-01-18	Polypeptider
BRPI0914649A2 (pt)	2015-07-07	Piprazolo-quinazolinas
DE602008003972D1 (de)	2011-01-27	Sitzrücklehnungsmechanismus
DE602008003521D1 (de)	2010-12-30	Sitzrücklehnungsmechanismus
DK2342454T3 (da)	2013-10-28	Vindkraftanlæg
DK2336132T3 (da)	2014-04-07	Morpholinpurinderivat
DK2335031T3 (da)	2019-08-26	In-line-måler
DK2379557T3 (da)	2012-12-17	Aminopyrazol-forbindelse
DK2271613T3 (da)	2014-07-14	Hydroxymethylcyklohexylaminer
DE602008003970D1 (de)	2011-01-27	Strahlstromkalibriersystem
EP2257170A4 (en)	2011-08-03	TETRAHYDROFUROPYRIDONE
DK2799428T3 (da)	2017-02-20	Glucagon-antagonister
EP2248964A4 (en)	2011-08-31	DRILLING / TERMINAL DEVICE
BRPI0907522A2 (pt)	2019-09-24	biarlamidas
DE112009000183A5 (de)	2011-02-03	Sicherheitsvorreiber
BRPI0909634A2 (pt)	2015-09-22	2-aminoquinolinas
DE602009000862D1 (de)	2011-04-28	Gehwagenbremse
EP2245356A4 (en)	2012-10-24	STRUCTURAL FIBER STRING, IMPREGNATED WITH RESIN

Legal Events

Date	Code	Title	Description
2015-12-08	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.